These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 34775024)

  • 1. C-reactive Protein, Free Fatty Acid, and Uric Acid as Predictors of Adverse Events after Endovascular Revascularization of Arterial Femoropopliteal Occlusion Lesions.
    Di X; Han W; Zhang R; Liu C; Zheng Y
    Ann Vasc Surg; 2022 Apr; 81():333-342. PubMed ID: 34775024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization.
    Stone PA; Schlarb H; Campbell JE; Williams D; Thompson SN; John M; Campbell JR; AbuRahma AF
    J Vasc Surg; 2014 Sep; 60(3):652-60. PubMed ID: 24795153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers in patients with open reconstructions with peripheral arterial disease.
    Stone PA; Thompson SN; Williams D; AbuRahma Z; Grome L; Schlarb H; AbuRahma AF
    Vascular; 2016 Oct; 24(5):461-8. PubMed ID: 26462536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-World Performance of Paclitaxel Drug-Eluting Bare Metal Stenting (Zilver PTX) for the Treatment of Femoropopliteal Occlusive Disease.
    Tran K; Ullery BW; Kret MR; Lee JT
    Ann Vasc Surg; 2017 Jan; 38():90-98. PubMed ID: 27554688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Biochemical Markers on Major Adverse Cardiovascular Events and Contralateral Carotid Artery Stenosis Progression Following Carotid Interventions.
    Stone PA; Thompson SN; Khan M; Northfield E; Schillinger R; Skaff P
    Ann Vasc Surg; 2017 Jan; 38():144-150. PubMed ID: 27546852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of the serum eicosapentaenoic acid to arachidonic acid ratio in relation to clinical outcomes after endovascular therapy in patients with peripheral artery disease caused by femoropopliteal artery lesions.
    Hishikari K; Kimura S; Yamakami Y; Kojima K; Sagawa Y; Otani H; Sugiyama T; Kuwahara T; Hikita H; Takahashi A; Isobe M
    Atherosclerosis; 2015 Apr; 239(2):583-8. PubMed ID: 25733330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term clinical outcomes and cause of death after endovascular treatment for femoropopliteal artery lesions.
    Fukase T; Dohi T; Kato Y; Chikata Y; Takahashi N; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Daida H; Minamino T
    J Cardiol; 2021 Apr; 77(4):417-423. PubMed ID: 33229235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (PAD).
    Takamura TA; Tsuchiya T; Oda M; Watanabe M; Saito R; Sato-Ishida R; Akao H; Kawai Y; Kitayama M; Kajinami K
    Atherosclerosis; 2017 Aug; 263():192-197. PubMed ID: 28651186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions.
    Dohi T; Iida O; Soga Y; Hirano K; Suzuki K; Takahara M; Uematsu M; Nanto S
    J Vasc Surg; 2014 Apr; 59(4):1009-1015.e1. PubMed ID: 24360237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between clinical outcomes and vessel size in endovascular therapy for femoropopliteal lesions.
    Hiramori S; Soga Y; Iida O; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Ando K
    J Vasc Surg; 2017 Jun; 65(6):1690-1697. PubMed ID: 28268108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of balloon angioplasty alone versus nitinol stent implantation in patients with small femoropopliteal artery disease: Observations from the Retrospective Multicenter Analysis for Femoropopliteal Stenting (REAL-FP).
    Kamioka N; Soga Y; Kuramitsu S; Iida O; Hirano K; Suzuki K; Kawasaki D; Yamaoka T; Suematsu N; Shintani Y; Miyashita Y; Takahashi H; Tsuchiya T; Shinozaki N; Okazaki S; Ando K
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):790-797. PubMed ID: 28722294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year prognosis after endovascular therapy in claudicant patients with iliofemoral artery disease.
    Miura T; Soga Y; Miyashita Y; Iida O; Kawasaki D; Hirano K; Suzuki K; Ikeda U
    J Endovasc Ther; 2014 Jun; 21(3):381-8. PubMed ID: 24915585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incident cardiovascular events and early mortality in patients with revascularized critical limb ischemia.
    Gaisset R; Lin F; Borry O; Quemeneur C; Lazareth I; Emmerich J; Priollet P; Yannoutsos A
    J Med Vasc; 2022 Feb; 47(1):19-26. PubMed ID: 35393087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of 2-Year Mortality and Risk Stratification After Surgical or Endovascular Revascularization of Infrainguinal Artery Disease in Hemodialysis Patients With Critical Limb Ischemia.
    Shiraki T; Iida O; Takahara M; Soga Y; Mii S; Okazaki J; Kuma S; Yamaoka T; Kamoi D; Shintani Y; Ishikawa T; Kitano I; Uematsu M
    J Endovasc Ther; 2015 Oct; 22(5):719-24. PubMed ID: 26276552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Post-Exercise Ankle-Brachial Index on Lower Extremity Revascularization.
    Hammad TA; Strefling JA; Zellers PR; Reed GW; Venkatachalam S; Lowry AM; Gornik HL; Bartholomew JR; Blackstone EH; Shishehbor MH
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1238-1244. PubMed ID: 26292588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic Assessment Before and After Endovascular Therapy for Critical Limb Ischemia and Association With Clinical Outcomes.
    Reed GW; Young L; Bagh I; Maier M; Shishehbor MH
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2451-2457. PubMed ID: 29153498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of C-reactive protein to albumin ratio for long-term outcomes of patients with peripheral arterial disease underwent endovascular treatment.
    Süleymanoğlu M; Burak C; Gümüşdağ A; Çap M; Şenol A; Hamideyin Ş; Güzel E; Rencüzoğulları İ; Karabağ Y; Çağdaş M
    Vascular; 2022 Jun; 30(3):481-489. PubMed ID: 34112027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease.
    Meltzer AJ; Shrikhande G; Gallagher KA; Aiello FA; Kahn S; Connolly P; McKinsey JF
    J Vasc Surg; 2012 Feb; 55(2):353-62. PubMed ID: 22051874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.